Circulation

Vol. 153, Issue 13 Issue 13 2026
17
Articles

Articles in this Issue

Letter by Xu and Sun Regarding Article, “Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study”

Jiaqian Xu, Yinghan Sun Mar 31, 2026 10.1161/circulationaha.125.076781

Forecasting the Burden of Cardiovascular Disease and Stroke in Women in the United States Through 2050: A Scientific Statement From the American Heart Association

Karen E. Joynt Maddox, Harmony R. Reynolds, Demilade Adedinsewo et al. Mar 31, 2026 10.1161/cir.0000000000001406

BACKGROUND: Forecasts for the future prevalence of cardiovascular disease and stroke are crucial to guide efforts to improve health outcomes across the life course for women....

Response by Gao et al to Letter Regarding Article, “G Protein–Coupled Receptor Kinase 3 Exacerbates Diabetic Heart Injuries Through Direct Phosphorylation of Cannabinoid Receptor 2 in Humans and Mice”

Pan Gao, Liliang Li, Yunzeng Zou Mar 31, 2026 10.1161/circulationaha.125.079055

Group 1 Pulmonary Hypertension With Elevated Pulmonary Artery Wedge Pressure: Characterizing A Complex Phenotype

Lindsay M. Forbes, William K. Cornwell Mar 31, 2026 pp. 963-966 10.1161/circulationaha.126.078855

Competing Risks in Cardiovascular Research: A Practical Perspective

Andrea Bellavia, Sabina A. Murphy Mar 31, 2026 pp. 945-947 10.1161/circulationaha.126.078513

Correction to: Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association

Mariann R. Piano, Gregory M. Marcus, Dawn M. Aycock et al. Mar 31, 2026 10.1161/cir.0000000000001430

Malnutrition and Cachexia in Inpatients With Acute Cardiac Conditions: A Scientific Statement From the American Heart Association

Amanda R. Vest, Robert J. DiDomenico, Lily Lichtenstein et al. Mar 31, 2026 10.1161/cir.0000000000001405

Malnutrition can affect patients with various acute cardiovascular disease conditions, including acute coronary syndromes, arrhythmias, or valvular disease; however, most of the literature has focused...

Pulmonary Arterial Hypertension Risk With BCR-ABL Tyrosine Kinase Inhibitors: Refining Risk With Nationwide Data

Jonah D. Garry, Evan L. Brittain Mar 31, 2026 pp. 980-982 10.1161/circulationaha.126.079012

Letter by Wu et al Regarding Article, “G Protein–Coupled Receptor Kinase 3 Exacerbates Diabetic Heart Injuries Through Direct Phosphorylation of Cannabinoid Receptor 2 in Humans and Mice”

Di Wu, Jing Zhang, Jian Yang Mar 31, 2026 10.1161/circulationaha.125.077325

Transient <i>Sprr1a</i> Expression Defines a Population of Border Zone Cardiomyocytes That Survive Ischemic Injury

Emily H. Marshall, Daniel A. Zuppo, Kimberly N. Burgos Villar et al. Mar 31, 2026 pp. 1001-1004 10.1161/circulationaha.125.075192

Letter by Meng et al Regarding Article, “An Aberrant Resurgence of Endogenous Retroviruses Prompts Myocarditis and Heart Failure”

Chang Meng, Yintang Wang, Guobin Miao Mar 31, 2026 10.1161/circulationaha.125.077923

Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design

Clement Jambon-Barbara, Samy Suissa, Sophie Dell’Aniello et al. Mar 31, 2026 pp. 967-979 10.1161/circulationaha.125.077764

BACKGROUND: BCR-ABL (fusion between the Abelson [Abl] tyrosine kinase gene at chromosome 9 and the break point cluster [Bcr] gene at chromosome 22) tyrosine kinase inhibitors (TKIs...

Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension

Yogesh N.V. Reddy, Robert P. Frantz, William R. Miranda et al. Mar 31, 2026 pp. 948-962 10.1161/circulationaha.125.077606

BACKGROUND: With pulmonary hypertension (PH), a pulmonary artery wedge pressure (PAWP)&gt;15 mm Hg is used to diagnose left heart dysfunction, but some patients with adjudicated gr...

Myocardial Infarction, Precision-Engineered T Regulatory Cells to the Rescue

Liwu Li Mar 31, 2026 pp. 998-1000 10.1161/circulationaha.126.078800

Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair

Min Zhang, Yongying Qin, Ting Zhou et al. Mar 31, 2026 pp. 983-997 10.1161/circulationaha.125.076321

BACKGROUND: Myocardial infarction (MI) initiates a dysregulated healing process characterized by excessive fibrosis and unresolved inflammation, resulting in suboptimal cardiac rep...

Response by Xiong and Zhang to Letter Regarding Article, “An Aberrant Resurgence of Endogenous Retroviruses Prompts Myocarditis and Heart Failure”

Junhao Xiong, Bing Zhang Mar 31, 2026 10.1161/circulationaha.125.079058

Response by Hundemer and Vaidya to Letter Regarding Article, “Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study”

Gregory L. Hundemer, Anand Vaidya Mar 31, 2026 10.1161/circulationaha.125.079057

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0009-7322
E-ISSN 1524-4539
Subject Health Sciences
Language English
View Full Journal Page